Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies pre-exposure prophylaxis and 1-year booster response in immunosuppressed adults with autoimmune disease
NL-OMON25639Recruiting
- Sponsor
- International Society of Travel Medicine
- Start
- Jun 2020
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Rabies vaccine in rabies, sponsored by International Society of Travel Medicine. Primary endpoint: Boostability at 1 year. Started Jun 2020; status: recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NL-OMON25639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25639.